Cargando…
Nanotechnology-based drug delivery for the treatment of CNS disorders
Approximately 6.8 million people die annually because of problems related to the central nervous system (CNS), and out of them, approximately 1 million people are affected by neurodegenerative diseases that include Alzheimer’s disease, multiple sclerosis, epilepsy, and Parkinson’s disease. CNS probl...
Autores principales: | Mittal, Khushi R., Pharasi, Nandini, Sarna, Bhavya, Singh, Manisha, Rachana, Haider, Shazia, Singh, Sachin Kumar, Dua, Kamal, Jha, Saurabh Kumar, Dey, Abhijit, Ojha, Shreesh, Mani, Shalini, Jha, Niraj Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883694/ https://www.ncbi.nlm.nih.gov/pubmed/36741545 http://dx.doi.org/10.1515/tnsci-2022-0258 |
Ejemplares similares
-
Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin
por: Thomas, Shilu Deepa, et al.
Publicado: (2023) -
Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update
por: Krishnan, Saravanan, et al.
Publicado: (2021) -
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021) -
Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies
por: Jha, Niraj Kumar, et al.
Publicado: (2020) -
Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review
por: Jha, Niraj Kumar, et al.
Publicado: (2022)